Brain drug trial aims to fix 'Lazy Eye' in older kids
NCT ID NCT07226141
Summary
This study is testing if adding a drug called valproate to standard patching therapy can improve vision in children and teens (ages 8-17) with a 'lazy eye' (amblyopia) that hasn't fully gotten better with glasses or patching alone. The goal is to see if valproate, which may help the brain's visual system become more adaptable, can lead to lasting vision improvement. Participants will wear an eye patch for 2 hours daily and take either valproate or a placebo pill for 16 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMBLYOPIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Boston Children's Waltham
Waltham, Massachusetts, 02453, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.